Manufacturing and Production
Amid growing fears of antimicrobial-resistance, NHS payment scheme aims for pharma to tackle superbugs
April 12, 2022 Manufacturing and Production
NICE has shared that cefiderocol, and ceftazidime/avibactam, have the potential to save lives. The two medications, which fight drug-resistant superbugs, …
VR solution for personalised treatment and surgery guidance to spine surgeons
April 12, 2022 Manufacturing and Production
Seymourpowell and Axis Spine Technologies have announced a virtual reality (VR) solution allowing surgeons to evaluate and develop spinal implants …
European Commission approves treatment of unresectable uveal melanoma
April 5, 2022 Manufacturing and Production
Immunocore Holdings has announced that the European Commission has approved KIMMTRAK® (tebentafusp) for the treatment of HLA-A*02:01-positive adult patients with …
Technology enabling thermally-controlled DNA synthesis
April 5, 2022 Manufacturing and Production
Evonetix has been granted a patent in Europe for thermal control technology for DNA synthesis, as well as the design …
NHS struggling to make progress on early cancer diagnosis
April 5, 2022 Manufacturing and Production
MPs have warned that the NHS in England is struggling to make progress on its flagship target to diagnose three-quarters …
FDA approves generic version of brain imaging agent in US
April 5, 2022 Manufacturing and Production
The FDA has approved the generic version of DaTscan (Ioflupane I 123), manufactured and commercialised by Curium. This is a …
FlyPharma Conference Europe: New dates and location announced
April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
CHMP recommends approval of Janssen’s first CAR-T therapy
March 29, 2022 Manufacturing and Production
Johnson & Johnson have announced the CHMP recommendation of marketing authorisation of ciltacabtagene autoleucel (cilta-cel) for the treatment of adults …
Telix granted FDA orphan drug designation for bone marrow conditioning treatment
March 29, 2022 Manufacturing and Production
The FDA has granted Orphan Drug Designation (ODD) for TLX66, for conditioning treatment prior to hematopoietic stem cell transplant (HSCT). …
Japan: drug approved for treatment of life-threatening bleeding
March 29, 2022 Manufacturing and Production
AstraZeneca has announced that Ondexxya has become the first approved medicine in Japan to reverse the anticoagulant effect of Factor …
BIMZELX effective for moderate to severe plaque psoriasis treatment
March 29, 2022 Manufacturing and Production
UCB has revealed results from its Phase III/IIIb trials of BIMZELX (bimekizumab) for the treatment of adults with moderate to …
FDA approval for first drug for rare form of epilepsy
March 22, 2022 Manufacturing and Production
Those living in the US with CDKL5 deficiency disorder, or CDD, may now have access to the first FDA-approved treatment …
MDMA improves PTSD symptoms, study finds
March 22, 2022 Manufacturing and Production
In findings presented at the American Chemical Society’s (ACS) Spring Meeting for 2022, researchers reported on follow-up results form a …
Pfizer recalls blood pressure drug due to potential carcinogen
March 22, 2022 Manufacturing and Production
Pfizer is voluntarily recalling certain hypertension medications due to the potential presence of impurities. The affected products have been distributed …
Collaboration to offer heart rhythm checks to detect atrial fibrillation
March 22, 2022 Manufacturing and Production
Daiichi Sankyo and O’Brien’s Pharmacies Group have today announced the launch of a collaboration in North West England to offer …
Latest content
